Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease

Background. Chronic renal replacement therapy patients exhibit reduction in skeletal muscle function as a result of a combination of metabolic effects and muscle fibre size reduction. The aim of this study was to compare muscle mass with function in patients with chronic kidney disease (CKD) at stag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2006-08, Vol.21 (8), p.2210-2216
Hauptverfasser: McIntyre, Christopher W., Selby, Nicholas M., Sigrist, Mhairi, Pearce, Lyndsay E., Mercer, Thomas H., Naish, Patrick F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2216
container_issue 8
container_start_page 2210
container_title Nephrology, dialysis, transplantation
container_volume 21
creator McIntyre, Christopher W.
Selby, Nicholas M.
Sigrist, Mhairi
Pearce, Lyndsay E.
Mercer, Thomas H.
Naish, Patrick F.
description Background. Chronic renal replacement therapy patients exhibit reduction in skeletal muscle function as a result of a combination of metabolic effects and muscle fibre size reduction. The aim of this study was to compare muscle mass with function in patients with chronic kidney disease (CKD) at stages 4 and 5 on haemodialysis (HD) and peritoneal dialysis (PD), and investigate the associations of muscle wasting in a cross-sectional cohort. Methods. We studied 134 patients (60 HD, 28 PD and 46 CKD 4). The three groups were well matched for age, sex, diabetes and dialysis vintage. Cross-sectional area (CSA) of muscle and fat was measured from a standardized multi-slice CT scan of a 6 cm long section of thigh. CSA of soft tissue was taken from appropriate fat and muscle densities. Functional assessment was by the sit-to-stand 60 test, assessing both the number of sit-to-stands possible under controlled conditions in 60 s (STS 60), and the time taken to perform five sit-to-stand movements (STS 5). Data were collected on a wide range of potential determinants of muscle CSA. Results. There were no significant differences in haemoglobin between males or females or between any of the groups studied. Serum phosphate and calcium-phosphate product were higher in HD patients as compared to CKD4 patients, but there were no differences in these variables when comparing PD patients with either CKD4 or HD patients. Muscle CSA correlated well with objective functional assessments in males (STS 60 R = 0.52, P
doi_str_mv 10.1093/ndt/gfl064
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68676347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68676347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-43b39395d80191a2ca4581db0370c19ddbb55d43fe3d7192808d5f1f1496e9eb3</originalsourceid><addsrcrecordid>eNpd0V1rFDEUBuBBFLtWb_wBEgS9EMYmk4-ZXJb6UbFgBQXxJmSSM7vpZjJrktm6_8ifaZZdW_Am5-I8eQN5q-o5wW8JlvQs2Hy2HDwW7EG1IEzguqEdf1gtypLUmGN5Uj1J6QZjLJu2fVydEMExky1bVH-udXYQckIRDLitC0s0ahcyBB0MIOu03yWX0EpvAY1TBJRgC2UMczDZTUF7v0PJLYMbnNEho7QGD1l7NM7JeEC3OuV9bF7pgDb_nrt1eXWXXrtgYQPlKPfNKk7BGbR2NsCumAQ6wdPq0aB9gmfHeVp9__D-28VlffXl46eL86vaMCJyzWhPJZXcdphIohujGe-I7TFtsSHS2r7n3DI6ALUtkU2HO8sHMhAmBUjo6Wn1-pC7idOvGVJWo0sGvNcBpjkp0YlWUNYW-PI_eDPNsXxHUg3pCGeS7NGbAzJxSinCoDbRjTruFMFqX54q5alDeQW_OCbO_Qj2nh7bKuDVEehktB9iqcile9dhKjCXxdUH51KG33d7HddKtLTl6vLHT8XFNW8-v2vVV_oXoSK2rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218154917</pqid></control><display><type>article</type><title>Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>McIntyre, Christopher W. ; Selby, Nicholas M. ; Sigrist, Mhairi ; Pearce, Lyndsay E. ; Mercer, Thomas H. ; Naish, Patrick F.</creator><creatorcontrib>McIntyre, Christopher W. ; Selby, Nicholas M. ; Sigrist, Mhairi ; Pearce, Lyndsay E. ; Mercer, Thomas H. ; Naish, Patrick F.</creatorcontrib><description>Background. Chronic renal replacement therapy patients exhibit reduction in skeletal muscle function as a result of a combination of metabolic effects and muscle fibre size reduction. The aim of this study was to compare muscle mass with function in patients with chronic kidney disease (CKD) at stages 4 and 5 on haemodialysis (HD) and peritoneal dialysis (PD), and investigate the associations of muscle wasting in a cross-sectional cohort. Methods. We studied 134 patients (60 HD, 28 PD and 46 CKD 4). The three groups were well matched for age, sex, diabetes and dialysis vintage. Cross-sectional area (CSA) of muscle and fat was measured from a standardized multi-slice CT scan of a 6 cm long section of thigh. CSA of soft tissue was taken from appropriate fat and muscle densities. Functional assessment was by the sit-to-stand 60 test, assessing both the number of sit-to-stands possible under controlled conditions in 60 s (STS 60), and the time taken to perform five sit-to-stand movements (STS 5). Data were collected on a wide range of potential determinants of muscle CSA. Results. There were no significant differences in haemoglobin between males or females or between any of the groups studied. Serum phosphate and calcium-phosphate product were higher in HD patients as compared to CKD4 patients, but there were no differences in these variables when comparing PD patients with either CKD4 or HD patients. Muscle CSA correlated well with objective functional assessments in males (STS 60 R = 0.52, P&lt;0.0001) and females (R = 0.41, P = 0.004), and STS performance was reduced in dialysed patients as compared with CKD 4. Univariate analysis demonstrated that muscle CSA was associated with serum albumin concentration (R = 0.49, P&lt;0.0001), age (R = −0.35, P = 0.005) and C-reactive protein (R = −0.34, P = 0.004). Creatinine clearance, dialysis adequacy, dialysis vintage and time-averaged serum bicarbonate, calcium and phosphate concentrations were not correlated with muscle CSA. Conclusion. In conclusion, patients with dialysis-treated CKD 5 exhibited more functionally significant muscle wasting than patients with CKD 4. This may be amenable to modification with targeted exercise or amelioration of factors associated with observed differences in muscle mass.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfl064</identifier><identifier>PMID: 16504974</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adipose Tissue - diagnostic imaging ; Adipose Tissue - pathology ; Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Anthropometry ; Bicarbonates - blood ; Biological and medical sciences ; Body Mass Index ; C-Reactive Protein - analysis ; Chronic Disease ; chronic kidney disease ; Cohort Studies ; Comorbidity ; computed tomography ; Cross-Sectional Studies ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Glomerulonephritis ; haemodialysis ; Hemoglobins - analysis ; Humans ; Intensive care medicine ; Kidney Diseases - complications ; Kidney Diseases - therapy ; Male ; Medical sciences ; Middle Aged ; Muscle, Skeletal - diagnostic imaging ; Muscle, Skeletal - pathology ; Muscular Atrophy - diagnostic imaging ; Muscular Atrophy - etiology ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; peritoneal dialysis ; Peritoneal Dialysis - adverse effects ; Phosphates - blood ; Renal Dialysis - adverse effects ; Serum Albumin - analysis ; Severity of Illness Index ; Single-Blind Method ; skeletal muscle ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Tomography, Spiral Computed ; Uremia - etiology ; Uremia - therapy ; wasting</subject><ispartof>Nephrology, dialysis, transplantation, 2006-08, Vol.21 (8), p.2210-2216</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright Oxford Publishing Limited(England) Aug 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-43b39395d80191a2ca4581db0370c19ddbb55d43fe3d7192808d5f1f1496e9eb3</citedby><cites>FETCH-LOGICAL-c416t-43b39395d80191a2ca4581db0370c19ddbb55d43fe3d7192808d5f1f1496e9eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18036059$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16504974$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McIntyre, Christopher W.</creatorcontrib><creatorcontrib>Selby, Nicholas M.</creatorcontrib><creatorcontrib>Sigrist, Mhairi</creatorcontrib><creatorcontrib>Pearce, Lyndsay E.</creatorcontrib><creatorcontrib>Mercer, Thomas H.</creatorcontrib><creatorcontrib>Naish, Patrick F.</creatorcontrib><title>Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. Chronic renal replacement therapy patients exhibit reduction in skeletal muscle function as a result of a combination of metabolic effects and muscle fibre size reduction. The aim of this study was to compare muscle mass with function in patients with chronic kidney disease (CKD) at stages 4 and 5 on haemodialysis (HD) and peritoneal dialysis (PD), and investigate the associations of muscle wasting in a cross-sectional cohort. Methods. We studied 134 patients (60 HD, 28 PD and 46 CKD 4). The three groups were well matched for age, sex, diabetes and dialysis vintage. Cross-sectional area (CSA) of muscle and fat was measured from a standardized multi-slice CT scan of a 6 cm long section of thigh. CSA of soft tissue was taken from appropriate fat and muscle densities. Functional assessment was by the sit-to-stand 60 test, assessing both the number of sit-to-stands possible under controlled conditions in 60 s (STS 60), and the time taken to perform five sit-to-stand movements (STS 5). Data were collected on a wide range of potential determinants of muscle CSA. Results. There were no significant differences in haemoglobin between males or females or between any of the groups studied. Serum phosphate and calcium-phosphate product were higher in HD patients as compared to CKD4 patients, but there were no differences in these variables when comparing PD patients with either CKD4 or HD patients. Muscle CSA correlated well with objective functional assessments in males (STS 60 R = 0.52, P&lt;0.0001) and females (R = 0.41, P = 0.004), and STS performance was reduced in dialysed patients as compared with CKD 4. Univariate analysis demonstrated that muscle CSA was associated with serum albumin concentration (R = 0.49, P&lt;0.0001), age (R = −0.35, P = 0.005) and C-reactive protein (R = −0.34, P = 0.004). Creatinine clearance, dialysis adequacy, dialysis vintage and time-averaged serum bicarbonate, calcium and phosphate concentrations were not correlated with muscle CSA. Conclusion. In conclusion, patients with dialysis-treated CKD 5 exhibited more functionally significant muscle wasting than patients with CKD 4. This may be amenable to modification with targeted exercise or amelioration of factors associated with observed differences in muscle mass.</description><subject>Adipose Tissue - diagnostic imaging</subject><subject>Adipose Tissue - pathology</subject><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Anthropometry</subject><subject>Bicarbonates - blood</subject><subject>Biological and medical sciences</subject><subject>Body Mass Index</subject><subject>C-Reactive Protein - analysis</subject><subject>Chronic Disease</subject><subject>chronic kidney disease</subject><subject>Cohort Studies</subject><subject>Comorbidity</subject><subject>computed tomography</subject><subject>Cross-Sectional Studies</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Glomerulonephritis</subject><subject>haemodialysis</subject><subject>Hemoglobins - analysis</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Kidney Diseases - complications</subject><subject>Kidney Diseases - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - diagnostic imaging</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscular Atrophy - diagnostic imaging</subject><subject>Muscular Atrophy - etiology</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>peritoneal dialysis</subject><subject>Peritoneal Dialysis - adverse effects</subject><subject>Phosphates - blood</subject><subject>Renal Dialysis - adverse effects</subject><subject>Serum Albumin - analysis</subject><subject>Severity of Illness Index</subject><subject>Single-Blind Method</subject><subject>skeletal muscle</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Tomography, Spiral Computed</subject><subject>Uremia - etiology</subject><subject>Uremia - therapy</subject><subject>wasting</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0V1rFDEUBuBBFLtWb_wBEgS9EMYmk4-ZXJb6UbFgBQXxJmSSM7vpZjJrktm6_8ifaZZdW_Am5-I8eQN5q-o5wW8JlvQs2Hy2HDwW7EG1IEzguqEdf1gtypLUmGN5Uj1J6QZjLJu2fVydEMExky1bVH-udXYQckIRDLitC0s0ahcyBB0MIOu03yWX0EpvAY1TBJRgC2UMczDZTUF7v0PJLYMbnNEho7QGD1l7NM7JeEC3OuV9bF7pgDb_nrt1eXWXXrtgYQPlKPfNKk7BGbR2NsCumAQ6wdPq0aB9gmfHeVp9__D-28VlffXl46eL86vaMCJyzWhPJZXcdphIohujGe-I7TFtsSHS2r7n3DI6ALUtkU2HO8sHMhAmBUjo6Wn1-pC7idOvGVJWo0sGvNcBpjkp0YlWUNYW-PI_eDPNsXxHUg3pCGeS7NGbAzJxSinCoDbRjTruFMFqX54q5alDeQW_OCbO_Qj2nh7bKuDVEehktB9iqcile9dhKjCXxdUH51KG33d7HddKtLTl6vLHT8XFNW8-v2vVV_oXoSK2rg</recordid><startdate>20060801</startdate><enddate>20060801</enddate><creator>McIntyre, Christopher W.</creator><creator>Selby, Nicholas M.</creator><creator>Sigrist, Mhairi</creator><creator>Pearce, Lyndsay E.</creator><creator>Mercer, Thomas H.</creator><creator>Naish, Patrick F.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20060801</creationdate><title>Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease</title><author>McIntyre, Christopher W. ; Selby, Nicholas M. ; Sigrist, Mhairi ; Pearce, Lyndsay E. ; Mercer, Thomas H. ; Naish, Patrick F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-43b39395d80191a2ca4581db0370c19ddbb55d43fe3d7192808d5f1f1496e9eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adipose Tissue - diagnostic imaging</topic><topic>Adipose Tissue - pathology</topic><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Anthropometry</topic><topic>Bicarbonates - blood</topic><topic>Biological and medical sciences</topic><topic>Body Mass Index</topic><topic>C-Reactive Protein - analysis</topic><topic>Chronic Disease</topic><topic>chronic kidney disease</topic><topic>Cohort Studies</topic><topic>Comorbidity</topic><topic>computed tomography</topic><topic>Cross-Sectional Studies</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Glomerulonephritis</topic><topic>haemodialysis</topic><topic>Hemoglobins - analysis</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Kidney Diseases - complications</topic><topic>Kidney Diseases - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - diagnostic imaging</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscular Atrophy - diagnostic imaging</topic><topic>Muscular Atrophy - etiology</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>peritoneal dialysis</topic><topic>Peritoneal Dialysis - adverse effects</topic><topic>Phosphates - blood</topic><topic>Renal Dialysis - adverse effects</topic><topic>Serum Albumin - analysis</topic><topic>Severity of Illness Index</topic><topic>Single-Blind Method</topic><topic>skeletal muscle</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Tomography, Spiral Computed</topic><topic>Uremia - etiology</topic><topic>Uremia - therapy</topic><topic>wasting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McIntyre, Christopher W.</creatorcontrib><creatorcontrib>Selby, Nicholas M.</creatorcontrib><creatorcontrib>Sigrist, Mhairi</creatorcontrib><creatorcontrib>Pearce, Lyndsay E.</creatorcontrib><creatorcontrib>Mercer, Thomas H.</creatorcontrib><creatorcontrib>Naish, Patrick F.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McIntyre, Christopher W.</au><au>Selby, Nicholas M.</au><au>Sigrist, Mhairi</au><au>Pearce, Lyndsay E.</au><au>Mercer, Thomas H.</au><au>Naish, Patrick F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2006-08-01</date><risdate>2006</risdate><volume>21</volume><issue>8</issue><spage>2210</spage><epage>2216</epage><pages>2210-2216</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. Chronic renal replacement therapy patients exhibit reduction in skeletal muscle function as a result of a combination of metabolic effects and muscle fibre size reduction. The aim of this study was to compare muscle mass with function in patients with chronic kidney disease (CKD) at stages 4 and 5 on haemodialysis (HD) and peritoneal dialysis (PD), and investigate the associations of muscle wasting in a cross-sectional cohort. Methods. We studied 134 patients (60 HD, 28 PD and 46 CKD 4). The three groups were well matched for age, sex, diabetes and dialysis vintage. Cross-sectional area (CSA) of muscle and fat was measured from a standardized multi-slice CT scan of a 6 cm long section of thigh. CSA of soft tissue was taken from appropriate fat and muscle densities. Functional assessment was by the sit-to-stand 60 test, assessing both the number of sit-to-stands possible under controlled conditions in 60 s (STS 60), and the time taken to perform five sit-to-stand movements (STS 5). Data were collected on a wide range of potential determinants of muscle CSA. Results. There were no significant differences in haemoglobin between males or females or between any of the groups studied. Serum phosphate and calcium-phosphate product were higher in HD patients as compared to CKD4 patients, but there were no differences in these variables when comparing PD patients with either CKD4 or HD patients. Muscle CSA correlated well with objective functional assessments in males (STS 60 R = 0.52, P&lt;0.0001) and females (R = 0.41, P = 0.004), and STS performance was reduced in dialysed patients as compared with CKD 4. Univariate analysis demonstrated that muscle CSA was associated with serum albumin concentration (R = 0.49, P&lt;0.0001), age (R = −0.35, P = 0.005) and C-reactive protein (R = −0.34, P = 0.004). Creatinine clearance, dialysis adequacy, dialysis vintage and time-averaged serum bicarbonate, calcium and phosphate concentrations were not correlated with muscle CSA. Conclusion. In conclusion, patients with dialysis-treated CKD 5 exhibited more functionally significant muscle wasting than patients with CKD 4. This may be amenable to modification with targeted exercise or amelioration of factors associated with observed differences in muscle mass.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>16504974</pmid><doi>10.1093/ndt/gfl064</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2006-08, Vol.21 (8), p.2210-2216
issn 0931-0509
1460-2385
language eng
recordid cdi_proquest_miscellaneous_68676347
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adipose Tissue - diagnostic imaging
Adipose Tissue - pathology
Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Anthropometry
Bicarbonates - blood
Biological and medical sciences
Body Mass Index
C-Reactive Protein - analysis
Chronic Disease
chronic kidney disease
Cohort Studies
Comorbidity
computed tomography
Cross-Sectional Studies
Emergency and intensive care: renal failure. Dialysis management
Female
Glomerulonephritis
haemodialysis
Hemoglobins - analysis
Humans
Intensive care medicine
Kidney Diseases - complications
Kidney Diseases - therapy
Male
Medical sciences
Middle Aged
Muscle, Skeletal - diagnostic imaging
Muscle, Skeletal - pathology
Muscular Atrophy - diagnostic imaging
Muscular Atrophy - etiology
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
peritoneal dialysis
Peritoneal Dialysis - adverse effects
Phosphates - blood
Renal Dialysis - adverse effects
Serum Albumin - analysis
Severity of Illness Index
Single-Blind Method
skeletal muscle
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Tomography, Spiral Computed
Uremia - etiology
Uremia - therapy
wasting
title Patients receiving maintenance dialysis have more severe functionally significant skeletal muscle wasting than patients with dialysis-independent chronic kidney disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T02%3A47%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients%20receiving%20maintenance%20dialysis%20have%20more%20severe%20functionally%20significant%20skeletal%20muscle%20wasting%20than%20patients%20with%20dialysis-independent%20chronic%20kidney%20disease&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=McIntyre,%20Christopher%20W.&rft.date=2006-08-01&rft.volume=21&rft.issue=8&rft.spage=2210&rft.epage=2216&rft.pages=2210-2216&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfl064&rft_dat=%3Cproquest_cross%3E68676347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218154917&rft_id=info:pmid/16504974&rfr_iscdi=true